|
Volumn 23, Issue 20, 2003, Pages
|
Viral vectors advance through drug pipelines
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AV 201;
B7 ANTIGEN;
BLOOD CLOTTING FACTOR 9;
CANCER VACCINE;
CARCINOEMBRYONIC ANTIGEN;
COAGULIN B;
DOPAMINE;
GAG PROTEIN;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
INTERCELLULAR ADHESION MOLECULE 1;
LEVODOPA;
LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3;
METRONIDAZOLE;
MUCIN 1;
NEF PROTEIN;
NERVE GROWTH FACTOR;
NEURTURIN;
POL PROTEIN;
PROSTATE SPECIFIC ANTIGEN;
PROSTATE SPECIFIC MEMBRANE ANTIGEN;
PROSTVAC VF;
RECOMBINANT DNA;
REXIN G;
SOMATOMEDIN C;
TNFERADE;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
VACCINE;
VON WILLEBRAND FACTOR;
ADENOVIRUS;
ALZHEIMER DISEASE;
ANTIBODY PRODUCTION;
ARTICLE;
CELLULAR IMMUNITY;
CLINICAL TRIAL;
FOWLPOX VIRUS;
GENE THERAPY;
GENETIC TRANSFECTION;
HEMOPHILIA B;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
NONHUMAN;
PANCREAS CANCER;
PARKINSON DISEASE;
POXVIRUS;
PROSTATE CANCER;
REPLICON;
RETROVIRUS VECTOR;
T LYMPHOCYTE;
VACCINATION;
VACCINIA VIRUS;
VIRAL GENE DELIVERY SYSTEM;
VIRAL GENE THERAPY;
VIRUS VECTOR;
ADENOVIRIDAE;
FOWLPOX VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS;
POXVIRIDAE;
UNIDENTIFIED RETROVIRUS;
VACCINIA VIRUS;
|
EID: 17644436680
PISSN: 02706377
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|